Is it time to routinely incorporate MRD into practice?

Publication date: Available online 21 September 2018Source: Best Practice & Research Clinical HaematologyAuthor(s): Farhad RavandiInterest in detecting minimal/measurable residual disease (MRD) in acute myeloid leukemia (AML) has been increasing, but numerous issues need to be addressed if MRD assessment is to be routinely incorporated into practice. Assays, their reliability, standardization, and availability all must be considered, and a strategy developed to eradicate residual leukemia. This paper reviews some issues surrounding the routine incorporation of MRD assessment into practice.
Source: Best Practice and Research Clinical Haematology - Category: Hematology Source Type: research